Colgate-Palmolive (NYSE:CL – Get Free Report) had its price objective upped by investment analysts at JPMorgan Chase & Co. from $97.00 to $99.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 10.25% from the stock’s current price.
A number of other analysts have also recently weighed in on CL. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Raymond James reiterated an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, Morgan Stanley decreased their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $101.72.
View Our Latest Research Report on CL
Colgate-Palmolive Trading Down 0.8 %
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business posted $0.87 EPS. On average, sell-side analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Colgate-Palmolive
Hedge funds and other institutional investors have recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $26,000. Centricity Wealth Management LLC purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Vermillion Wealth Management Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $31,000. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Finally, Briaud Financial Planning Inc purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $32,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Which Wall Street Analysts are the Most Accurate?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Why Are Stock Sectors Important to Successful Investing?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Should You Invest in Penny Stocks?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.